Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menevit Anti-Oxidant Therapy for Male Infertility
NCT00100269Phase 3Completed
- Sponsor
- ReproMed
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Menevit in male infertility, sponsored by ReproMed. Started Dec 2004; status: completed.
02
Drugs
Menevit
03
Conditions
male infertility
Beyond the preview
Go deeper on NCT00100269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100269.